Literature DB >> 10825200

Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: activation of syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation.

Y J Zhou1, K S Magnuson, T P Cheng, M Gadina, D M Frucht, J Galon, F Candotti, R L Geahlen, P S Changelian, J J O'Shea.   

Abstract

Interleukin-2 (IL-2) activates several different families of tyrosine kinases, but precisely how these kinases interact is not completely understood. We therefore investigated the functional relationships among Jak3, Lck, and Syk in IL-2 signaling. We first observed that in the absence of Jak3, both Lck and Syk had the capacity to phosphorylate Stat3 and Stat5a. However, neither supported IL-2-induced STAT activation, nor did dominant negative alleles of these kinases inhibit. Moreover, pharmacological abrogation of Lck activity did not inhibit IL-2-mediated phosphorylation of Jak3 and Stat5a. Importantly, ligand-dependent Syk activation was dependent on the presence of catalytically active Jak3, whereas Lck activation was not. Interestingly, Syk functioned as a direct substrate of Jak1 but not Jak3. Additionally, Jak3 phosphorylated Jak1, whereas the reverse was not the case. Taken together, our data support a model in which Lck functions in parallel with Jak3, while Syk functions as a downstream element of Jaks in IL-2 signaling. Jak3 may regulate Syk catalytic activity indirectly via Jak1. However, IL-2-mediated Jak3/Stat activation is not dependent on Lck or Syk. While the essential roles of Jak1 and Jak3 in signaling by gammac-utilizing cytokines are clear, it will be important to dissect the exact contributions of Lck and Syk in mediating the effects of IL-2 and related cytokines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10825200      PMCID: PMC85804          DOI: 10.1128/MCB.20.12.4371-4380.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  Profound block in thymocyte development in mice lacking p56lck.

Authors:  T J Molina; K Kishihara; D P Siderovski; W van Ewijk; A Narendran; E Timms; A Wakeham; C J Paige; K U Hartmann; A Veillette
Journal:  Nature       Date:  1992-05-14       Impact factor: 49.962

Review 2.  STATs: signal transducers and activators of transcription.

Authors:  J N Ihle
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

3.  T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p56lck.

Authors:  I D Horak; R E Gress; P J Lucas; E M Horak; T A Waldmann; J B Bolen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

4.  c-fos gene induction by interleukin 2: identification of the critical cytoplasmic regions within the interleukin 2 receptor beta chain.

Authors:  M Hatakeyama; A Kawahara; H Mori; H Shibuya; T Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 5.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

6.  Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans.

Authors:  M Noguchi; H Yi; H M Rosenblatt; A H Filipovich; S Adelstein; W S Modi; O W McBride; W J Leonard
Journal:  Cell       Date:  1993-04-09       Impact factor: 41.582

7.  Effects of p56lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-cell line.

Authors:  L Karnitz; S L Sutor; T Torigoe; J C Reed; M P Bell; D J McKean; P J Leibson; R T Abraham
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

8.  IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc.

Authors:  H Shibuya; M Yoneyama; J Ninomiya-Tsuji; K Matsumoto; T Taniguchi
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

9.  Interleukin 2-induced activation of Ras requires two domains of interleukin 2 receptor beta subunit, the essential region for growth stimulation and Lck-binding domain.

Authors:  T Satoh; Y Minami; T Kono; K Yamada; A Kawahara; T Taniguchi; Y Kaziro
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

10.  Association of p56lck with IL-2 receptor beta chain is critical for the IL-2-induced activation of p56lck.

Authors:  Y Minami; T Kono; K Yamada; N Kobayashi; A Kawahara; R M Perlmutter; T Taniguchi
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  14 in total

Review 1.  Roles of TRAF3 in T cells: many surprises.

Authors:  Zuoan Yi; Alicia M Wallis; Gail A Bishop
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Network pharmacology of JAK inhibitors.

Authors:  Devapregasan Moodley; Hideyuki Yoshida; Sara Mostafavi; Natasha Asinovski; Adriana Ortiz-Lopez; Peter Symanowicz; Jean-Baptiste Telliez; Martin Hegen; James D Clark; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-11       Impact factor: 11.205

3.  Combinatorial Signal Transduction Responses Mediated by Interleukin-2 and -4 Receptors in a Helper TH2 Cell Line.

Authors:  Kristen K Comfort; Jason M Haugh
Journal:  Cell Mol Bioeng       Date:  2008-09       Impact factor: 2.321

4.  Human immunodeficiency virus-1 envelope glycoproteins and anti-CD4 antibodies inhibit interleukin-2-induced Jak/STAT signalling in human CD4 T lymphocytes.

Authors:  M Kryworuchko; V Pasquier; J Thèze
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

Review 5.  JAKs go nuclear: emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth.

Authors:  Fouad A Zouein; Roy J Duhé; George W Booz
Journal:  Growth Factors       Date:  2011-09-05       Impact factor: 2.511

6.  Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.

Authors:  Andrew E Schade; Gary L Schieven; Robert Townsend; Anna M Jankowska; Vojkan Susulic; Rosemary Zhang; Hadrian Szpurka; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2007-10-25       Impact factor: 22.113

7.  Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models.

Authors:  Melanie G Cornejo; Michael G Kharas; Miriam B Werneck; Séverine Le Bras; Sandra A Moore; Brian Ball; Marie Beylot-Barry; Scott J Rodig; Jon C Aster; Benjamin H Lee; Harvey Cantor; Jean-Philippe Merlio; D Gary Gilliland; Thomas Mercher
Journal:  Blood       Date:  2009-01-12       Impact factor: 22.113

Review 8.  Role of intracellular signaling pathways and their inhibitors in the treatment of inflammation.

Authors:  Namrata P Nailwal; Gaurav M Doshi
Journal:  Inflammopharmacology       Date:  2021-05-17       Impact factor: 4.473

9.  Integrating signals from the T-cell receptor and the interleukin-2 receptor.

Authors:  Tilo Beyer; Mandy Busse; Kroum Hristov; Slavyana Gurbiel; Michal Smida; Utz-Uwe Haus; Kathrin Ballerstein; Frank Pfeuffer; Robert Weismantel; Burkhart Schraven; Jonathan A Lindquist
Journal:  PLoS Comput Biol       Date:  2011-08-04       Impact factor: 4.475

10.  Specific Jak3 Downregulation in Lymphocytes Impairs γc Cytokine Signal Transduction and Alleviates Antigen-driven Inflammation In Vivo.

Authors:  Alicia G Gómez-Valadés; María Llamas; Sílvia Blanch; José C Perales; Juan Román; Lluís Gómez-Casajús; Cristina Mascaró
Journal:  Mol Ther Nucleic Acids       Date:  2012-09-04       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.